Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00005593. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01062490. IPD Sharing: Not stated. Countries: 1. Publications: 1.
MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry
ClinicalTrials.gov study NCT01347944. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00047268. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01892644. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant
ClinicalTrials.gov study NCT00107354. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
ClinicalTrials.gov study NCT01241500. IPD Sharing: Not stated. Countries: 6. Publications: 4.
Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00104962. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00614523. IPD Sharing: Not stated. Countries: 0. Publications: 6.
Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01342692. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04128748. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00981240. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Topotecan in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00003675. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00413114. IPD Sharing: Not stated. Countries: 2. Publications: 1.
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT03896269. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04401748. IPD Sharing: YES. Countries: 23. Publications: 1.
Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015
ClinicalTrials.gov study NCT02320656. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Natural Killer Cells in Acute Leukaemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02123836. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02243124. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02060409. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.